跳至主要内容
临床试验/NCT00384306
NCT00384306已完成1 期

Investigation of the Side Effects of Orally Administered Glucocorticoids. An Open Label Study to Investigate the Effects of Orally Administered Prednisolone on Bone Metabolism in Patients With COPD.

GlaxoSmithKline2 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2004年6月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
9
试验地点
2
主要终点
Mineral apposition rate Mineralising surface Eroded surface Bone formation rate Osteocalcin levels Serum and urinary deoxypyridinoline

研究概览

简要总结

The aim of this study is to establish associations between blood and urine markers of bone metabolism with histomorphometric changes (changes in the actual bone structure) resulting from short term oral prednisolone treatment in patients with COPD (chronic obstructive pulmonary disease).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Females subjects must be unable to have children.
  • BMI 19 - 29.9
  • Non-smokers, ex-smokers or current light smokers (<10 cigarettes/day)

排除标准

  • High blood pressure
  • Other significant disease
  • Use of certain medications (to be decided by the investigator)

结局指标

主要结局

Mineral apposition rate Mineralising surface Eroded surface Bone formation rate Osteocalcin levels Serum and urinary deoxypyridinoline

时间窗: All measured with and without 3 weeks dosing with oral prednisolone

次要结局

  • Pharmacokinetic measurements Bone structure and micro computer tomography of bone biopsies Biochemical markers of bone formation, bone break down and hormones(All measured with and without 3 weeks dosing with oral prednisolone)

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验

Effects Of Oral Prednisolone On Bone Metabolism In... | 临床试验